Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B (02493)) has announced a new board appointment.
According to a company filing, Dr. Gui Xun was elected as an employee representative director to the company's third-term board of directors.
The election took place during the seventh meeting of the first session of the company's labor union committee, which was held concurrently with a staff and workers' congress on June 18, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments